Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma

Rank: 36

Tokyo and Osaka, Japan
www.ds-pharma.com

2020 Revenues ($USD) : $4,521,371,043
2020 Revenues (foreign currencies) : JP¥482,792,000,000
2020 R&D spend : $867,269,152
2020 Number of Employees : 3,023
Fiscal Year End : 3/31/2020
Key People : Hiroshi Nomura, CEO

Formed in 2005 from the merger of Dainippon Pharmaceutical Co. and Sumitomo Pharmaceuticals, Sumitomo Dainippon Pharma has focused on boosting flexibility and efficiency in recent years. The company has a goal of establishing its position as a "Global Specialized Player" by 2033, according to its 2020 annual report. Focus areas include psychiatry and neurology, diabetes, respiratory and infectious diseases. –CN

Sumitomo

A Sumitomo Dainippon Pharma R&D facility

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50